These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37167134)

  • 21. Prevalence and clinicopathological Spectrum of Auto-Immune Liver Diseases & Overlap syndrome.
    Varadarajan A; Rastogi A; Maiwall R; Bihari C; Thomas S; Sood V; Shasthry SM
    Indian J Pathol Microbiol; 2024; 67(1):107-114. PubMed ID: 38358198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.
    Gabeta S; Norman GL; Gatselis N; Liaskos C; Papamichalis PA; Garagounis A; Zachou K; Rigopoulou EI; Dalekos GN
    J Clin Immunol; 2008 Sep; 28(5):501-11. PubMed ID: 18551357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease.
    Moreira RK; Revetta F; Koehler E; Washington MK
    World J Gastroenterol; 2010 Jan; 16(4):453-7. PubMed ID: 20101770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta-analysis.
    Jensen AH; Winther-Sørensen M; Burisch J; Bergquist A; Ytting H; Gluud LL; Wewer Albrechtsen NJ
    Liver Int; 2023 Nov; 43(11):2479-2491. PubMed ID: 37752719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosing clinical subsets of autoimmune liver diseases based on a multivariable model.
    Zeniya M; Watanabe F; Morizane T; Shibata M; Maeyama S; Kage M; Nakanuma Y; Toda G;
    J Gastroenterol; 2005 Dec; 40(12):1148-54. PubMed ID: 16378179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.
    Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW
    United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases.
    Steinmann S; Hartl J; Weidemann S; Füssel K; Kroll C; Sebode M; Lohse AW; Schramm C
    JHEP Rep; 2023 Dec; 5(12):100898. PubMed ID: 37954487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.
    Webb GJ; Rana A; Hodson J; Akhtar MZ; Ferguson JW; Neuberger JM; Vierling JM; Hirschfield GM
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):278-287.e7. PubMed ID: 28993258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occult hepatitis B virus infection in patients with autoimmune liver diseases.
    Georgiadou SP; Zachou K; Liaskos C; Gabeta S; Rigopoulou EI; Dalekos GN
    Liver Int; 2009 Mar; 29(3):434-42. PubMed ID: 18694399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of gut microbiota in autoimmune liver diseases.
    Qian Q; He W; Tang R; Ma X
    Minerva Gastroenterol (Torino); 2023 Mar; 69(1):95-106. PubMed ID: 33793160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.
    Boberg KM; Aadland E; Jahnsen J; Raknerud N; Stiris M; Bell H
    Scand J Gastroenterol; 1998 Jan; 33(1):99-103. PubMed ID: 9489916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autoimmune liver diseases].
    Fischer HP; Goltz D
    Pathologe; 2020 Sep; 41(5):444-456. PubMed ID: 32749523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune liver diseases.
    Bylund DJ; McHutchison J
    Clin Lab Med; 1997 Sep; 17(3):483-97. PubMed ID: 9316770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases.
    Silveira MG; Lindor KD
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):329-40. PubMed ID: 19072425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study.
    Fu Y; Li J; Zhu Y; Chen C; Liu J; Gu S; Zheng Y; Li Y
    BMC Med Genomics; 2023 Oct; 16(1):232. PubMed ID: 37789337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan.
    Tanaka A; Mori M; Matsumoto K; Ohira H; Tazuma S; Takikawa H
    Hepatol Res; 2019 Aug; 49(8):881-889. PubMed ID: 30932290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review: recurrent autoimmune liver diseases after liver transplantation.
    Montano-Loza AJ; Bhanji RA; Wasilenko S; Mason AL
    Aliment Pharmacol Ther; 2017 Feb; 45(4):485-500. PubMed ID: 27957759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
    Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
    JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.
    Sebode M; Weiler-Normann C; Liwinski T; Schramm C
    Front Immunol; 2018; 9():609. PubMed ID: 29636752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.